Supplementary Figure 2 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Justine Michaux
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
81Publications signalées
2539Citations signalées
0Affiliations récentes
Les domaines associés
Immunotherapy and Immune ResponsesCAR-T cell therapy researchvaccines and immunoinformatics approachesMonoclonal and Polyclonal Antibodies ResearchFerroptosis and cancer prognosis
Les publications récentes
Supplementary Figure 3 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Supplementary Figure 5 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Supplementary Figure 9 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Supplementary Figure 6 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Supplementary Figure 8 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Supplementary Figure 4 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Supplementary Figure 1 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Supplementary Figure 7 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers et autres
0 citations
Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics
Ilja E. Shapiro, Florian Huber, Justine Michaux, Michal Bassani‐Sternberg
ch (code pays fourni par la source)
16 citations
Nature Communications
Circulating tumor‐associated and neoantigen‐specific endogenous T cells in children treated for B‐acute lymphoblastic leukemia
Eliane Huwiler, Anne‐Christine Thierry, Justine Michaux, HuiSong Pak et autres
ch (code pays fourni par la source)
0 citations
HemaSphere
Phage display enables machine learning discovery of cancer antigen–specific TCRs
Giancarlo Croce, Rachid Lani, Delphine Tardivon, Sara Bobisse et autres
ch (code pays fourni par la source)
18 citations
Science Advances
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.